Northwest Biotherapeutics Inc (NWBO)

Sector: Healthcare
Industry: Biotechnology
Last price: $0.17
As of: 2026-11-06

Kresmion compiles this page from NWBO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

NORTHWEST BIOTHERAPEUTICS INC (NWBO): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-30.

As of 2026-10-30, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest event other than 13F-derived events. Source: SEC EDGAR filings for NWBO. Method and limitations.

COMPANY DOSSIER

See the full NWBO dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for NWBO on one page. Preview it with sample data, then open it live with a free account.

Preview the NWBO dossier

Active events for NWBO

mediumEarnings below estimates2026-05-31
Q1-2014: Missed consensus by 121.2% - EPS $-0.88 vs $-0.3978 estimate
All 2026-05-31 events →

FREE, NO ACCOUNT

Every event on NWBO, as it fires

New filings, 13F moves and cross asset events on NWBO land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, NWBO

8-K2026-10-30
SEC EDGAR ↗
10-Q2026-08-14
SEC EDGAR ↗
8-K2026-07-31
SEC EDGAR ↗
8-K2026-07-20
SEC EDGAR ↗
10-Q2026-05-15
SEC EDGAR ↗
10-K2026-04-15
SEC EDGAR ↗
8-K2026-04-07
SEC EDGAR ↗
8-K2026-01-15
SEC EDGAR ↗
8-K2026-01-02
SEC EDGAR ↗
8-K2025-11-20
SEC EDGAR ↗

Going concern statement

NWBO's 10-Q filed Aug 14, 2026 states:

Because of recurring operating losses and operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for at least one year from the date of this filing.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on NWBO

NWBO against its peers Growth, margins and valuation beside the industry median, from annual SEC filings.

NWBO mentioned in Kresmion daily briefs

Kresmion brief, 2026-05-17

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in NWBO on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on NWBO in the last 180 days.

Upstream: SEC EDGAR filings for NWBO

Kresmion, "NORTHWEST BIOTHERAPEUTICS INC (NWBO) institutional holdings and SEC filings", data as of 2026-10-30, https://kresmion.com/research/NWBO. Upstream data: SEC EDGAR filings for NWBO.

Link to this data (HTML):

<a href="https://kresmion.com/research/NWBO">NORTHWEST BIOTHERAPEUTICS INC (NWBO) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow NWBO on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to NWBO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the NWBO dossier

The NWBO intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.